[SEEDO'2000 consensus for the evaluation of overweight and obesity and the establishment of criteria for therapeutic intervention. Sociedad Española para el Estudio de la Obesidad].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000627:therapeutic use; D015904:Biliopancreatic Diversion; D001835:Body Weight; D002648:Child; D003430:Cross-Sectional Studies; D003503:Cyclobutanes / Q000627:therapeutic use; D004032:Diet; D015444:Exercise; D005260:Female; D015390:Gastric Bypass; D015391:Gastroplasty; D006266:Health Education; D006801:Humans; D007783:Lactones / Q000627:therapeutic use; D008019:Life Style; D008297:Male; D008875:Middle Aged; D009747:Nutritional Physiological Phenomena; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D009767:Obesity, Morbid / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D000077403:Orlistat; D011322:Primary Prevention; D011613:Psychotherapy; D012307:Risk Factors; D012737:Sex Factors; D013030:Spain / Q000453:epidemiology
D019440:Anti-Obesity Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D007783:Lactones; D000077403:Orlistat; C058254:sibutramine